Skip to content

Bioavailability, Biopotency and Food effect study of SCD0503 compared to subcutaneous regular human insulin

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519502-12-00
Enrollment
16
Registered
2026-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

None listed

Sponsors

Samchundang Pharm. Co. Ltd.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: May 30, 2026